Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dianne, DeLucia"'
Autor:
Evan J, Anderson, C Buddy, Creech, Vladimir, Berthaud, Arin, Piramzadian, Kimball A, Johnson, Marcus, Zervos, Fredric, Garner, Carl, Griffin, Khozema, Palanpurwala, Mark, Turner, Jeffrey, Gerber, Richard L, Bennett, Kashif, Ali, Madhavi, Ampajwala, Gary, Berman, Jennifer, Nayak, Carey, Chronis, Barbara, Rizzardi, William J, Muller, Christopher A, Smith, George, Fuchs, Daniel, Hsia, Joanne E, Tomassini, Dianne, DeLucia, Caroline, Reuter, Barbara, Kuter, Xiaoping, Zhao, Weiping, Deng, Honghong, Zhou, Daniela, Ramirez Schrempp, Kelly, Hautzinger, Bethany, Girard, Karen, Slobod, Roderick, McPhee, Rolando, Pajon, Anne, Aunins, Rituparna, Das, Jacqueline M, Miller, Sabine, Schnyder Ghamloush, Yamna, Ali
Publikováno v:
The New England journal of medicine. 387(18)
The safety, reactogenicity, immunogenicity, and efficacy of the mRNA-1273 coronavirus disease 2019 (Covid-19) vaccine in young children are unknown.Part 1 of this ongoing phase 2-3 trial was open label for dose selection; part 2 was an observer-blind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87d962af5aa5330e6d7710b72ead9c40
https://pubmed.ncbi.nlm.nih.gov/36260859
https://pubmed.ncbi.nlm.nih.gov/36260859
Autor:
Brian Yu, Ellie Hershberger, Dianne DeLucia, Jennifer A. Huntington, Alan Xiao, Adedayo Adedoyin, Elizabeth G. Rhee, Luzelena Caro, Kajal B. Larson
Publikováno v:
Open Forum Infectious Diseases. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff4e6702b6bcda37756c2d46b73a841c
https://doi.org/10.1093/ofid/ofw172.1513
https://doi.org/10.1093/ofid/ofw172.1513
Autor:
Jhanelle E. Gray, Dianne DeLucia, S. Strychor, G. J. Riely, J. Dunbar, R. G. Stoller, Grace K. Dy, Scott N. Gettinger, C. Tunkey, N. Y. Gabrail, Glen J. Weiss, G. Skliris, Robert W. Ross
Publikováno v:
Journal of Clinical Oncology. 29:7516-7516
7516 Background: IPI-504, a water-soluble analog of 17-allylamino-17-demethoxygeldanamycin (17-AAG), is an intravenously (IV) administered heat shock protein 90 (Hsp90) inhibitor that causes degrad...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::641a200e961e9d727c034d0b7a4796e9
https://doi.org/10.1200/jco.2011.29.15_suppl.7516
https://doi.org/10.1200/jco.2011.29.15_suppl.7516